Catherine Karns
About Catherine Karns
Catherine Karns is a Senior Manager at Bristol Myers Squibb, leading global early immunology and fibrosis strategy and forecasting.
Company
Catherine Karns is currently working at Bristol Myers Squibb in Princeton, New Jersey, United States. She holds the position of Senior Manager, Global Early Immunology and Fibrosis Lead - Enterprise Strategy & Forecasting. Her work involves strategic forecasting and enterprise strategy within the early immunology and fibrosis sector.
Title
As the Senior Manager, Global Early Immunology And Fibrosis Lead - Enterprise Strategy & Forecasting at Bristol Myers Squibb, Catherine Karns is responsible for leading strategic initiatives and forecasting models for therapies in the early stages of immunology and fibrosis.
Education and Expertise
Catherine Karns studied Biomolecular Science at the University of Michigan, where she achieved a Bachelor of Science (BS) from 2015 to 2019. Her educational background provides a solid foundation for her expertise in the fields of immunology and fibrosis, enhancing her role in enterprise strategy and forecasting.
Career Background
Catherine Karns has worked in various roles before joining Bristol Myers Squibb. She served as Assistant Vice President, Senior Associate, Associate, and Junior Associate at Argot Partners, LLC in New York, New York from 2019 to 2022. Additionally, she gained experience as an intern at McKinsey & Company in 2018 and co-founded two University of Michigan medical technology startups. Early in her career, she worked as a Surgical & Clinical Intern at Thunder Basin Orthopaedics.
Achievements
Catherine Karns has several notable achievements, including leading a cross-functional team to develop a strategic forecasting model for early immunology and fibrosis therapies. She has also presented research findings at a major industry conference in 2023 and published a white paper on early intervention in fibrosis treatment. Her contributions have been recognized with an internal award for excellence in enterprise strategy and forecasting at Bristol Myers Squibb. Additionally, she mentors junior analysts and new hires in her team.